Company / Shareholders' Equity
HERBALIFE LTD. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$515.1M
FY2025
5-year range
-$1.4B / -$390.0M
FY2021-FY2025
Trend
+35.7%
vs FY2024
Sector context
#156 of 161
Health Care
What the data says
HERBALIFE LTD. reports negative total equity of -$515M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$515M in FY2025.
Improved from -$1.4B to -$515M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 161This company -$515.1M Sector average $5.1B
▼
-110.2% below sector average
Key checks
Key Insights
- In FY2025, shareholders' equity increased 35.7% year-over-year.
- Ranks #156 out of 161 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2018.
- Lowest shareholders' equity in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$515.1M | +35.7% |
| FY2024 | -$801.1M | +42.4% |
| FY2023 | -$1.4B | -9.9% |
| FY2022 | -$1.3B | -224.6% |
| FY2021 | -$390.0M | +46.1% |
| FY2020 | -$723.4M | -116.1% |
| FY2019 | -$334.7M | -270.5% |
| FY2018 | $196.3M | +466.9% |
| FY2017 | -$53.5M | +84.0% |
| FY2016 | -$334.4M | -160.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026